A Phase III, Randomized, Double-Blind, Placebo Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis
Latest Information Update: 29 Jul 2020
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Hyperhidrosis
- Focus Registrational; Therapeutic Use
- Sponsors Medytox
- 27 Jul 2020 Status changed from recruiting to completed.
- 04 Dec 2018 New trial record